With box warnings

Without box warnings

Branded

Generic

4 results

cyramza
(ramucirumab)
Eli Lilly and Company
Usage: CYRAMZA is indicated for treating advanced or metastatic gastric/gastro-esophageal junction cancer, non-small cell lung cancer (NSCLC), colorectal cancer, and hepatocellular carcinoma in specific patient populations following prior treatments with chemotherapy or targeted therapies. It can be used alone or in combination with other agents.
lipiodol
(ethiodized oil)
Guerbet LLC
Usage: Lipiodol is an oil-based radio-opaque contrast agent used for hysterosalpingography in adults, lymphography in adults and pediatric patients, and selective hepatic intra-arterial imaging of tumors in adults with hepatocellular carcinoma (HCC).
tecentriq
(atezolizumab)
Genentech, Inc.
Usage: TECENTRIQ is indicated for treating various cancers, including: non-small cell lung cancer (adjuvant and metastatic), extensive-stage small cell lung cancer, unresectable or metastatic hepatocellular carcinoma, BRAF V600 mutation-positive melanoma, and unresectable or metastatic alveolar soft part sarcoma.
yervoy
(ipilimumab)
E.R. Squibb & Sons, L.L.C.
Usage: YERVOY is indicated for treating unresectable or metastatic melanoma, adjuvant melanoma post-resection, advanced renal cell carcinoma, microsatellite instability-high colorectal cancer, hepatocellular carcinoma, metastatic non-small cell lung cancer, malignant pleural mesothelioma, and unresectable esophageal cancer, often in combination with nivolumab.

Medications for Adult Hepatocellular Carcinoma

cyramza